Zhang Yi

This profile gathers the share dealings of Zhang Yi across 7 companies, led by Peijia Medical Ltd. - B, Hua Medicine - B and China Baoli Technologies Holdings Ltd. Between 23 January 2018 and 3 June 2026, the trades on record add up to 35 filings.

Market trades split into 19 purchases (€31.7M) and 7 sales (€1.3M). No amount is published for 6 filings, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2026 to date brings 9 purchases and 1 sale.

A typical purchase (the median) is worth €132k. Relative to company size, the median is 0.068% of market cap (9 purchases with a known value). Of 14 purchases, 14 formed part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. Ninety days after publication, 6 purchases show a median change of -27.4%, with the price up in 17% of them. Past outcomes like these are no guarantee of what comes next.

The latest filing, published on 8 June 2026, reports an open-market purchase of €22k in Peijia Medical Ltd. - B. Filings reach the HKEX feed a median of 4 days after the trade. The shorter that gap, the sooner other investors can see what insiders have done. This summary is built from HKEX disclosures alone and does not predict where the share price will go.